ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

VP Joe Biden Will Not Host Komen’s Global Race for the Cure in D.C.

May 11, 2012

Jury Finds USC Geneticist William French Anderson Guilty of Sexual Abuse of a Child.

July 28, 2006

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

NCI To Sponsor Its Own Predoctoral Training At Some Institutions With Postdoctoral Awards

January 31, 1975

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

NCAB Committee Approves Recompletion Of Support Contracts

October 7, 1988